ReviewCNS drugs2022

High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing-Remitting Multiple Sclerosis.

Léorah Freeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.